Tal Zvi Zaks, Chief Medical Officer at Moderna, Inc. (MRNA), sold 8,013 shares at $187.10 ($1.5M) on 2021-05-03, disclosed to the SEC on 2021-05-04.
Open-market sale of $1.5M MRNA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $183.42 | 271 | $50K | 3.3% |
| 2 | $184.77 | 800 | $148K | 9.9% |
| 3 | $186.04 | 1,089 | $203K | 13.6% |
| 4 | $186.04 | 1,089 | $203K | 13.6% |
| 5 | $187.10 | 1,924 | $360K | 24.1% |
| 6 | $187.10 | 1,924 |
| $360K |
| 24.1% |
| 7 | $188.00 | 916 | $172K | 11.5% |
| Total | $186.56 avg | 8,013 | $1.5M | 100% |
| Filing → |
| MRNA | SELL | 2021-06-25 | $1.1M | — | Filing → |
| MRNA | SELL | 2021-06-21 | $1.0M | — | Filing → |
| MRNA | SELL | 2021-06-11 | $1.1M | — | Filing → |